Former UFC champion Matt Serra is not happy with former bantamweight champion TJ Dillashaw. Dillashaw vacated his title after testing positive for the synthetic hormone EPO, which landed him a two-year suspension from the U.S. Anti-Doping Agency (USADA).
Serra did not hold back when discussing Dillashaw in the latest edition of the “UFC Unfiltered” podcast.
The “Ultimate Fighter” winner blasted Dillashaw for being a “cheater” and indicated he strongly believes Dillashaw was using EPO even before his failed experiment at flyweight — which resulted in a 32-second knockout loss to 125-pound champ Henry Cejudo.
“It’s downright disgusting. What legacy? What (expletive) legacy? We don’t know what he could have done if the playing field was even – on a level playing field,” Serra said. “I really feel for Cody. I do – because in that first fight, in the first one, he hurt (Dillashaw), too. He almost took him out. Maybe that slight edge was because he’s a (expletive) cheater. I never had a problem with that kid, and I always got along with (coach) Duane (Ludwig). But this is just foul.
“Cody Garbrandt – who knows what that takes out of the rest of his career? How about that, T.J.? What does it take out of this kid’s career that he gets stopped twice by a (expletive) cheater? He might not have as long as a career, so he might not have as many options to make the money that he would have made. That sounds dramatic, but that’s the (expletive) truth of it.
“So (expletive) you, T.J. This is (expletive) bull(expletive). This is disgusting. I can’t say it enough. Everyone that got stopped by him should be furious and at the same time, look at yourself and go, ‘All right. Now it makes sense. Now it makes (expletive) sense (that I lost to him).’”
You can listen to the full comments below.
Dillashaw made his flyweight debut in his most recent outing against 125-pound champion Henry Cejudo. In the bout, Dillashaw suffered a 30-second knockout loss which snapped a four-fight winning streak.
The 33-year-old Dillashaw cannot return to action until 2021.